124 related articles for article (PubMed ID: 9167961)
1. V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors.
de Keyzer Y; René P; Lenne F; Auzan C; Clauser E; Bertagna X
Horm Res; 1997; 47(4-6):259-62. PubMed ID: 9167961
[TBL] [Abstract][Full Text] [Related]
2. The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.
de Keyzer Y; Lenne F; Auzan C; Jégou S; René P; Vaudry H; Kuhn JM; Luton JP; Clauser E; Bertagna X
J Clin Invest; 1996 Mar; 97(5):1311-8. PubMed ID: 8636444
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
de Keyzer Y; René P; Beldjord C; Lenne F; Bertagna X
Clin Endocrinol (Oxf); 1998 Oct; 49(4):475-82. PubMed ID: 9876345
[TBL] [Abstract][Full Text] [Related]
4. Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.
de Keyzer Y; Bertagna X; Lenne F; Girard F; Luton JP; Kahn A
J Clin Invest; 1985 Nov; 76(5):1892-8. PubMed ID: 2997296
[TBL] [Abstract][Full Text] [Related]
5. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
6. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of the human V3 pituitary vasopressin receptor.
de Keyzer Y; Auzan C; Lenne F; Beldjord C; Thibonnier M; Bertagna X; Clauser E
FEBS Lett; 1994 Dec; 356(2-3):215-20. PubMed ID: 7805841
[TBL] [Abstract][Full Text] [Related]
8. High expression of the POU factor Brn3a in aggressive neuroendocrine tumors.
Leblond-Francillard M; Picon A; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 1997 Jan; 82(1):89-94. PubMed ID: 8989239
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
Dahia PL; Ahmed-Shuaib A; Jacobs RA; Chew SL; Honegger J; Fahlbusch R; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1996 May; 81(5):1768-71. PubMed ID: 8626831
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the V3 vasopressin receptor in transgenic mice corticotropes leads to increased basal corticosterone.
René P; Grino M; Viollet C; Videau C; Jullian E; Bucchini D; Epelbaum J; Bertagna X; de Keyzer Y
J Neuroendocrinol; 2002 Sep; 14(9):737-44. PubMed ID: 12213135
[TBL] [Abstract][Full Text] [Related]
12. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.
Arnaldi G; Gasc JM; de Keyzer Y; Raffin-Sanson ML; Perraudin V; Kuhn JM; Raux-Demay MC; Luton JP; Clauser E; Bertagna X
J Clin Endocrinol Metab; 1998 Jun; 83(6):2029-35. PubMed ID: 9626135
[TBL] [Abstract][Full Text] [Related]
13. Gene and cDNA cloning and characterization of the mouse V3/V1b pituitary vasopressin receptor.
Ventura MA; René P; de Keyzer Y; Bertagna X; Clauser E
J Mol Endocrinol; 1999 Jun; 22(3):251-60. PubMed ID: 10343284
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
[TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries.
Sanno N; Jin L; Qian X; Osamura RY; Scheithauer BW; Kovacs K; Lloyd RV
J Clin Endocrinol Metab; 1997 Jun; 82(6):1974-82. PubMed ID: 9177416
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
Auernhammer CJ; Melmed S
Endocrinology; 1999 Apr; 140(4):1559-66. PubMed ID: 10098488
[TBL] [Abstract][Full Text] [Related]
17. Ectopic ACTH Cushing's syndrome: V3 vasopressin receptor but not CRH receptor gene expression in a pulmonary carcinoid tumor.
Chabot V; de Keyzer Y; Gebhard S; Uské A; Bischof-Delaloye A; Rey F; Dusmet M; Gomez F
Horm Res; 1998; 50(4):226-31. PubMed ID: 9838245
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.
Pascual-Le Tallec L; Dulmet E; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 2002 Nov; 87(11):5015-22. PubMed ID: 12414866
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.
Hsu DW; Hooi SC; Hedley-Whyte ET; Strauss RM; Kaplan LM
Am J Pathol; 1991 Apr; 138(4):897-909. PubMed ID: 1707237
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.
Arnaldi G; de Keyzer Y; Gasc JM; Clauser E; Bertagna X
Endocr Res; 1998; 24(3-4):807-16. PubMed ID: 9888581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
